Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Masahiko Ichiyama"'
Autor:
Masahiko Ichiyama, Shigeo Tano, Takashi Nishizono, Ken Kimura, Kiichi Tamada, Shinichi Wada, Toshiyuki Aizawa, Kenichi Ido, Akira Oohashi, Takeshi Tomiyama
Publikováno v:
Gastrointestinal Endoscopy. 47:28-32
Objective : To determine the influence of biliary drainage catheter placement on bile duct wall thickness, we performed intraductal ultrasonography (IDUS) in patients before and after biliary drainage. Methods : Patients underwent IDUS before and aft
Autor:
Norio Ueno, Takeshi Tomiyama, Kenkichi Tokumaru, Ken Kimura, Shigeo Tano, Masaki Fukuda, Toshiyasu Iwao, Toshiyuki Aizawa, Kiichi Tamada, Masahiko Ichiyama, Takashi Nishizono
Publikováno v:
Progress of Digestive Endoscopy(1972). 44:143-146
Autor:
Naoki Sakurai, Ryutaro Asano, Hideaki Kodama, Hisaaki Saeki, Toshio Kudo, Masao Shinoda, Masahiko Ichiyama, Kohzoh Imai, Masanori Suzuki, Hiroshi Yoshida, Yuji Hinoda, Seiki Matsuno, Shin Ichi Takemura, Yu Katayose
Publikováno v:
Immunology letters. 81(2)
For the purpose of establishing a new adoptive immunotherapy for bile duct carcinoma (BDC), we previously constructed two kinds of bispecific antibodies (bsAbs), anti-MUC1 x anti-CD3 (M x 3) and anti-MUC1 x anti-CD28 (M x 28), which activate T cells
Autor:
Kohei Tsumoto, Seiki Matsuno, Izumi Kumagai, Naoki Sakurai, Hiroshi Yoshida, Hisaaki Saeki, Ryutaro Asano, Shin Ichi Takemura, Masao Shinoda, Toshio Kudo, Yuji Hinoda, Hideaki Kodama, Yu Katayose, Masanori Suzuki, Masahiko Ichiyama, Kohzoh Imai
Publikováno v:
Cancer immunology, immunotherapy : CII. 50(10)
For the purpose of establishing a new adoptive immunotherapy for bile duct carcinoma (BDC), we have directed our attention to superantigens (SAgs), the most potent known activators of T lymphocytes. In our previous study, staphylococcal enterotoxin A
Autor:
Hideaki Kodama, Seiki Matsuno, Toshio Kudo, Jitsuko Takahashi, Tsuyoshi Tominaga, Shinichi Takemura, Hiroshi Yoshida, Masanori Suzuki, Yu Katayose, Masao Shinoda, Hisaaki Saeki, Masahiko Ichiyama, Naoki Sakurai, Susumu Saijyo
Publikováno v:
The Tohoku journal of experimental medicine. 188(4)
In order to enhance cell mediated cytotoxicity, bispecific antibodies (BsAbs), molecules combining two or more antibodies with different antigenic specificities, have been developed as new agents for immunotherapy. Our recent studies revealed that si
Autor:
Masahiko Ichiyama, Kimiyuki Shibusawa, Masahiko Ohtani, Yasuhisa Kumakura, Chiaki Kawamoto, Ken Kimura, Kenichi Ido
Publikováno v:
THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE. 10:163-165